KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Shares Issued (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Shares Issued data on record, last reported at $308000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 91.7% year-over-year to $308000.0; the TTM value through Dec 2025 reached $19.0 million, down 76.12%, while the annual FY2025 figure was $18.7 million, 76.48% down from the prior year.
  • Shares Issued reached $308000.0 in Q4 2025 per SRPT's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $39.9 million in Q2 2024 and bottomed at -$49.3 million in Q4 2023.
  • Average Shares Issued over 5 years is $7.3 million, with a median of $5.9 million recorded in 2021.
  • The widest YoY moves for Shares Issued: up 1628.91% in 2023, down 536.19% in 2023.
  • A 5-year view of Shares Issued shows it stood at $2.1 million in 2021, then skyrocketed by 426.21% to $11.3 million in 2022, then crashed by 536.19% to -$49.3 million in 2023, then soared by 107.52% to $3.7 million in 2024, then crashed by 91.7% to $308000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $308000.0 in Q4 2025, $1.2 million in Q3 2025, and $3.7 million in Q4 2024.